• 6767 Bertner Ave, Mitchell Basic Science Research Building

    77030 Houston

    United States

  • 2735 Citations
  • 18 h-Index
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Michael Curran is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 2 Similar Profiles
Neoplasms Medicine & Life Sciences
T-Lymphocytes Medicine & Life Sciences
Immunotherapy Medicine & Life Sciences
Feline Immunodeficiency Virus Medicine & Life Sciences
CTLA-4 Antigen Medicine & Life Sciences
Immunity Medicine & Life Sciences
Cancer Vaccines Medicine & Life Sciences
Genetic Therapy Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2000 2019

  • 2735 Citations
  • 18 h-Index
  • 34 Article
  • 6 Review article
  • 1 Editorial
  • 1 Letter
32 Citations (Scopus)

Combining Immune Checkpoint Blockade and Tumor-Specific Vaccine for Patients with Incurable Human Papillomavirus 16-Related Cancer: A Phase 2 Clinical Trial

Massarelli, E., William Jr, W. N., Johnson, F. M., Kies, M. S., Ferrarotto, R., Guo, M., Feng, L., Lee, J-K. J., Tran, H. T., Kim, Y. U., Haymaker, C. L., Bernatchez, C., Curran, M., Zecchini Barrese, T., Rodriguez Canales, J., Wistuba, I. I., Li, L., Wang, J., Van Der Burg, S. H., Melief, C. J. & 1 others, Glisson, B. S., Jan 1 2019, In : JAMA Oncology. 5, 1, p. 67-73 7 p.

Research output: Contribution to journalArticle

Cancer Vaccines
Human papillomavirus 16
Clinical Trials

Discovery of IACS-8803 and IACS-8779, potent agonists of stimulator of interferon genes (STING) with robust systemic antitumor efficacy

Ager, C. R., Zhang, H., Wei, Z., Jones, P., Curran, M. & Di Francesco, M. E., Oct 15 2019, In : Bioorganic and Medicinal Chemistry Letters. 29, 20, 126640.

Research output: Contribution to journalArticle

Chemical activation
1 Citation (Scopus)
Allergy and Immunology
3 Citations (Scopus)

New hope for therapeutic cancer vaccines in the era of immune checkpoint modulation

Curran, M. & Glisson, B. S., Jan 27 2019, In : Annual Review of Medicine. 70, p. 409-424 16 p.

Research output: Contribution to journalReview article

Cancer Vaccines
2 Citations (Scopus)

Oncogenic lncRNA downregulates cancer cell antigen presentation and intrinsic tumor suppression

Hu, Q., Ye, Y., Chan, L. C., Li, Y., Liang, K., Lin, A., Egranov, S. D., Zhang, Y., Xia, W., Gong, J., Pan, Y., Chatterjee, S. S., Yao, J., Evans, K. W., Nguyen, T. K., Park, P. K., Liu, J., Coarfa, C., Donepudi, S. R., Putluri, V. & 17 others, Putluri, N., Sreekumar, A., Ambati, C. R., Hawke, D. H., Marks, J. R., Gunaratne, P. H., Caudle, A. S., Sahin, A. A., Hortobagyi, G. N., Meric-Bernstam, F., Chen, L., Yu, D., Hung, M-C., Curran, M., Han, L., Lin, C. & Yang, L., Jul 1 2019, In : Nature Immunology. 20, 7, p. 835-851 17 p.

Research output: Contribution to journalArticle

Long Noncoding RNA
Triple Negative Breast Neoplasms
Antigen Presentation
Human Mammary Glands